177Lu放射性药物治疗后生活废水处理及核医学科衰变池规划的探讨

Considerations for Wastewater Management Following 177Lu Radiopharmaceutical Therapy and Planning for Decay Tanks in Nuclear Medicine Departments

  • 摘要: 2021年9月,环境保护厅发布了HJ1188-2021《核医学辐射防护与安全要求》。该法律规定了核医学辐射防护与安全要求,包括放射性废水贮存及排放等核医学科衰变池的相关内容。近年来,随着68Ga/177Lu诊疗一体化技术的发展,接受放射性核素治疗患者生活废水中含有的放射性废水对医疗环境、医护人员及周边生态的影响,将成为医院核医学科建设与发展过程中需要重点应对的挑战。通过177Lu治疗药物生物剂量学研究以及测量患者接受放射性核素治疗后洗浴废水放射性剂量得出结论:患者经过177Lu治疗当天及之后洗浴产生的日常废水可直接排入中央废水处理系统。笔者从177Lu治疗药物治疗后生活废水和核医学科衰变池建设规划2个方面,分析学习国内外辐射防护及废水处理的政策和经验,旨在借鉴国际先进的管理方式与技术,推进国内核医学科的发展。

     

    Abstract: In September 2021, the Environmental Protection Agency issued HJ1188-2021 "Radiation Protection and Safety Requirements for Nuclear Medicine", specifying radiation protection and safety requirements for nuclear medicine. This includes regulations on the storage and discharge of radioactive liquid waste and other aspects related to nuclear medicine decay pools. With the recent development in the integrated diagnosis and treatment of 68Ga/177Lu, The influence of radioactive wastewater contained in the domestic wastewater of patients receiving radionuclide treatment on the medical environment, medical staff and surrounding ecology will become a key challenge to be dealt with in the construction and development of nuclear medicine department in hospitals. The author analyzes domestic and foreign policies and experiences in radiation protection and wastewater treatment, focusing on domestic wastewater after 177Lu therapeutic drug treatment and the construction planning of decay ponds in nuclear medicine. The aim is to draw on international advanced management methods and technologies to promote the development of nuclear medicine.

     

/

返回文章
返回